SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Piffer OT - And Other Assorted Nuts

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jorj X Mckie who wrote (55366)10/5/2000 6:40:47 PM
From: The Phoenix  Read Replies (1) of 63513
 
GLW aint done yet!

fool.com

Corning Expands Into Biotech Chips

Corning, a contender in Drip Port's new high-growth company study, is using its core
technologies and production capacity to enter the competitive, emerging DNA biochip market. Corning enters a
field led by biochip leader Affymetrix, but Corning's technology may enable it to produce biochips 10 to 20 times
faster than they are commonly produced today. Meanwhile, Corning's telecom business continues to expand.

By Vince Hanks
October 5, 2000

When you think of a 149-year-old glass company, the first word that comes to mind usually isn't
"innovative." That is, however, exactly what Corning (NYSE: GLW) has become in recent years. CEO Roger
Ackerman has placed high priority on research and development (R&D) and has hired more than 700
scientists and engineers over the last three years. The dividends on that investment are already rolling in.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext